biospecimen__admin__batch_number	153.74.0
biospecimen__admin__bcr	Nationwide Children's Hospital
biospecimen__admin__day_of_dcc_upload	1
biospecimen__admin__disease_code	LIHC
biospecimen__admin__file_uuid	2AAC369E-D4C4-4FA4-92DC-148501CE9043
biospecimen__admin__month_of_dcc_upload	7
biospecimen__admin__year_of_dcc_upload	2016
biospecimen__bio__bcr_analyte_barcode	TCGA-G3-A25X-01A-11R
biospecimen__bio__bcr_portion_barcode	TCGA-G3-A25X-01A-11
biospecimen__bio__bcr_sample_barcode	TCGA-G3-A25X-01A
biospecimen__bio__biospecimen_barcode_bottom	0113422298
biospecimen__bio__day_of_creation	06
biospecimen__bio__day_of_shipment	05
biospecimen__bio__days_to_index	0
biospecimen__bio__gel_image_file	https://sharedoc.nchri.org/tcga-bcr/default.aspx
biospecimen__bio__is_derived_from_ffpe	NO
biospecimen__bio__month_of_creation	05
biospecimen__bio__month_of_shipment	07
biospecimen__bio__pathology_report_file_name	TCGA-G3-A25X.7DF1A9E2-3A8F-4A9B-B918-4133D60E4F0A.pdf
biospecimen__bio__plate_column	6
biospecimen__bio__plate_id	A16S
biospecimen__bio__plate_row	B
biospecimen__bio__portion_sequence	1
biospecimen__bio__quantity	3.60
biospecimen__bio__subportion_sequence	1
biospecimen__bio__vial_number	A
biospecimen__bio__volume	20.00
biospecimen__bio__year_of_creation	2011
biospecimen__bio__year_of_shipment	2011
biospecimen__shared__bcr_patient_barcode	TCGA-G3-A25X
biospecimen__shared__patient_id	A25X
clinical__admin__day_of_dcc_upload	22
clinical__admin__file_uuid	DCFA3A6F-3221-493D-AEC9-C69E30CE6FA7
clinical__admin__month_of_dcc_upload	12
clinical__admin__withdrawn	false
clinical__chol_lihc_shared__albumin_result_lower_limit	0.3
clinical__chol_lihc_shared__albumin_result_specified_value	0.4
clinical__chol_lihc_shared__albumin_result_upper_limit	0.5
clinical__chol_lihc_shared__bilirubin_lower_limit	0.0
clinical__chol_lihc_shared__bilirubin_upper_limit	1.1
clinical__chol_lihc_shared__child_pugh_classification_grade	A
clinical__chol_lihc_shared__creatinine_lower_level	0.4
clinical__chol_lihc_shared__creatinine_upper_limit	1.4
clinical__chol_lihc_shared__creatinine_value_in_mg_dl	0.8
clinical__chol_lihc_shared__fetoprotein_outcome_lower_limit	0
clinical__chol_lihc_shared__fetoprotein_outcome_upper_limit	10
clinical__chol_lihc_shared__fetoprotein_outcome_value	11
clinical__chol_lihc_shared__fibrosis_ishak_score	1,2 - Portal Fibrosis
clinical__chol_lihc_shared__hist_hepato_carc_fact	Hepatitis B
clinical__chol_lihc_shared__inter_norm_ratio_lower_limit	0.9
clinical__chol_lihc_shared__intern_norm_ratio_upper_limit	1.1
clinical__chol_lihc_shared__platelet_result_lower_limit	150
clinical__chol_lihc_shared__platelet_result_upper_limit	400
clinical__chol_lihc_shared__prothrombin_time_result_value	1.0
clinical__chol_lihc_shared__specimen_collection_method_name	Segmentectomy, Single
clinical__chol_lihc_shared__total_bilirubin_upper_limit	1.4
clinical__chol_lihc_shared__vascular_tumor_cell_type	None
clinical__clin_shared__age_at_initial_pathologic_diagnosis	73
clinical__clin_shared__bcr_followup_barcode	TCGA-G3-A25X-F33634
clinical__clin_shared__bcr_followup_uuid	760DCAB0-1B6D-4EB0-B802-4938BBA8157E
clinical__clin_shared__day_of_form_completion	11
clinical__clin_shared__days_to_initial_pathologic_diagnosis	0
clinical__clin_shared__eastern_cancer_oncology_group	0
clinical__clin_shared__followup_case_report_form_submission_reason	Scheduled Follow-up Submission
clinical__clin_shared__informed_consent_verified	YES
clinical__clin_shared__month_of_form_completion	7
clinical__clin_shared__person_neoplasm_cancer_status	TUMOR FREE
clinical__clin_shared__platelet_result_count	102
clinical__clin_shared__post_op_ablation_embolization_tx	NO
clinical__clin_shared__postoperative_rx_tx	NO
clinical__clin_shared__radiation_therapy	NO
clinical__clin_shared__relative_family_cancer_history	NO
clinical__clin_shared__residual_tumor	R0
clinical__clin_shared__tissue_prospective_collection_indicator	NO
clinical__clin_shared__tissue_retrospective_collection_indicator	YES
clinical__clin_shared__tumor_tissue_site	Liver
clinical__clin_shared__year_of_form_completion	2012
clinical__clin_shared__year_of_initial_pathologic_diagnosis	2007
clinical__lihc__adjacent_hepatic_tissue_inflammation_extent_type	Mild
clinical__nte__new_tumor_event_after_initial_treatment	NO
clinical__shared__histological_type	Hepatocellular Carcinoma
clinical__shared__history_of_neoadjuvant_treatment	No
clinical__shared__neoplasm_histologic_grade	G3
clinical__shared__other_dx	No
clinical__shared_stage__pathologic_m	M0
clinical__shared_stage__pathologic_n	N0
clinical__shared_stage__pathologic_t	T2
clinical__shared_stage__system_version	6th
gdc__access	open
gdc__acl	open
gdc__aliquots__aliquot_id	14c1cee3-d3b8-4a66-8d98-81881a278732
gdc__aliquots__concentration	0.18
gdc__aliquots__source_center	23
gdc__aliquots__submitter_id	TCGA-G3-A25X-01A-11R-A16S-13
gdc__aliquots__updated_datetime	2018-09-06T14:13:07.098771-05:00
gdc__analysis__analysis_id	c4be00dc-faa0-442f-a2a0-658cfcb7aed1
gdc__analysis__workflow_link	https://github.com/NCI-GDC/gdc-dnaseq-cwl/blob/gdc-active-submission/workflows/mirnaseq/runner.cwl
gdc__analysis__workflow_type	BCGSC miRNA Profiling
gdc__analytes__a260_a280_ratio	1.85
gdc__analytes__analyte_id	2f3d194f-58bf-48ba-bf72-2a2b848ed696
gdc__analytes__analyte_type	RNA
gdc__analytes__analyte_type_id	R
gdc__analytes__spectrophotometer_method	UV Spec
gdc__case_id	08428220-abd4-484e-85ca-3673454c837e
gdc__center__center_id	6eba705a-0f00-5aa2-b1d0-04dbf62100cc
gdc__center__center_type	CGCC
gdc__center__code	13
gdc__center__name	Canada's Michael Smith Genome Sciences Centre
gdc__center__namespace	bcgsc.ca
gdc__center__short_name	BCGSC
gdc__created_datetime	2018-03-20T12:54:50.037061-05:00
gdc__data_category	Transcriptome Profiling
gdc__data_format	TXT
gdc__data_type	miRNA Expression Quantification
gdc__demographic__demographic_id	77ce6b8f-5eaa-5a38-8c07-766b759ffddd
gdc__demographic__ethnicity	not hispanic or latino
gdc__demographic__gender	male
gdc__demographic__race	asian
gdc__demographic__year_of_birth	1934
gdc__diagnoses__age_at_diagnosis	26988
gdc__diagnoses__classification_of_tumor	not reported
gdc__diagnoses__days_to_birth	-26988.0
gdc__diagnoses__days_to_last_follow_up	1779.0
gdc__diagnoses__diagnosis_id	27c48002-8a70-56d3-b6ca-5104f9a453ea
gdc__diagnoses__last_known_disease_status	not reported
gdc__diagnoses__morphology	8170/3
gdc__diagnoses__primary_diagnosis	Hepatocellular carcinoma NOS
gdc__diagnoses__prior_malignancy	not reported
gdc__diagnoses__progression_or_recurrence	not reported
gdc__diagnoses__site_of_resection_or_biopsy	Liver
gdc__diagnoses__tissue_or_organ_of_origin	Liver
gdc__diagnoses__tumor_grade	not reported
gdc__diagnoses__tumor_stage	stage ii
gdc__diagnoses__vital_status	alive
gdc__disease_type	Adenomas and Adenocarcinomas
gdc__experimental_strategy	miRNA-Seq
gdc__exposures__bmi	23.875114784205692
gdc__exposures__exposure_id	08b31f3c-ecd5-591b-bc5e-8a84b1e502b7
gdc__exposures__height	165.0
gdc__exposures__weight	65.0
gdc__file_id	56fcca8f-339f-4f81-8157-7b5d3d5b753a
gdc__file_name	de0f9891-174c-4b34-a73a-d91b614d7703.mirbase21.mirnas.quantification.txt
gdc__file_size	50401
gdc__input_files__data_category	Raw Sequencing Data
gdc__input_files__data_format	BAM
gdc__input_files__data_type	Aligned Reads
gdc__input_files__experimental_strategy	miRNA-Seq
gdc__input_files__platform	Illumina
gdc__md5sum	754dac60de78f81589d05fa7ea64a4f7
gdc__portions__is_ffpe	false
gdc__portions__portion_id	607f1c28-ccb2-401b-b53f-ea265e496132
gdc__portions__portion_number	11
gdc__portions__weight	30.0
gdc__primary_site	Liver and intrahepatic bile ducts
gdc__program__dbgap_accession_number	phs000178
gdc__program__name	TCGA
gdc__program__program_id	b80aa962-9650-5110-b3eb-bd087da808db
gdc__project__disease_type	Liver Hepatocellular Carcinoma
gdc__project__primary_site	Liver
gdc__project__project_id	TCGA-LIHC
gdc__project__releasable	false
gdc__project__released	true
gdc__samples__days_to_collection	1346
gdc__samples__initial_weight	160.0
gdc__samples__oct_embedded	true
gdc__samples__pathology_report_uuid	7DF1A9E2-3A8F-4A9B-B918-4133D60E4F0A
gdc__samples__sample_id	5ff97822-0520-45b7-a28a-a1c68c5ac324
gdc__samples__sample_type	Primary Tumor
gdc__samples__sample_type_id	01
gdc__slides__percent_lymphocyte_infiltration	0.0
gdc__slides__percent_monocyte_infiltration	0.0
gdc__slides__percent_necrosis	0.0
gdc__slides__percent_neutrophil_infiltration	0.0
gdc__slides__percent_normal_cells	0.0
gdc__slides__percent_stromal_cells	35.0
gdc__slides__percent_tumor_cells	65.0
gdc__slides__percent_tumor_nuclei	70.0
gdc__slides__section_location	TOP
gdc__slides__slide_id	475ced16-bd9e-4353-a6d3-124a51c71716
gdc__submitter_id	mirna_swap_dr11_415_MirnaExpressioneeb5679d-86df-4e7c-b774-3a2991afe459_profiling
gdc__tissue_source_site__bcr_id	NCH
gdc__tissue_source_site__code	G3
gdc__tissue_source_site__name	Alberta Health Services
gdc__tissue_source_site__tissue_source_site_id	addd7b04-91a3-5179-99a5-cbff20df6bb4
gdc__treatments__treatment_id	2ee4d32f-3aeb-5d21-af8a-47d260ad2501
gdc__type	mirna_expression
gdc__updated_datetime	2018-09-08T13:43:34.032262+00:00
manually_curated__data_format	BED
manually_curated__download_date	2018-11-06T09:07:11.989+01:00
manually_curated__exp_data_bed_url	ftp://bioinformatics.iasi.cnr.it/opengdc/bed/tcga/tcga-lihc/mirna_expression_quantification/14c1cee3-d3b8-4a66-8d98-81881a278732-meq.bed
manually_curated__exp_metadata_url	ftp://bioinformatics.iasi.cnr.it/opengdc/bed/tcga/tcga-lihc/mirna_expression_quantification/14c1cee3-d3b8-4a66-8d98-81881a278732-meq.bed.meta
manually_curated__genome_built	GRCh38
manually_curated__local_file_size	129772
manually_curated__local_md5	5ee14c15cf03c1aed4a18e5cd3428488
manually_curated__opengdc_download_date	2018-10-16T17:12:11.000100+02:00
manually_curated__opengdc_file_md5	4cf709d48d0a0f44d0e19c23fdf140d0
manually_curated__opengdc_file_size	50400
manually_curated__opengdc_id	14c1cee3-d3b8-4a66-8d98-81881a278732-meq
manually_curated__origin_file_size	129772
manually_curated__origin_last_modified_date	Tue Oct 16 17:54:00 CEST 2018
manually_curated__origin_md5	5ee14c15cf03c1aed4a18e5cd3428488
manually_curated__tissue_status	tumoral
